weekly semaglutide injections Poviztra (semaglutide) is a prescription, once-weekly injection used for chronic weight management and blood sugar regulation in adults with obesity or type 2 diabetes. It is a GLP-1 receptor agonist, which mimics Wegovy® Pen Guide and Dosing

Store at 2-35C (36-77F)

Support meaningful weight loss: Studies show that semaglutide (Wegovy) can lead to an average weight loss of about 15%, while people taking tirzepatide (Zepbound) lost an average of 21% of body weight

While often hailed as the next frontier in the medical treatment of autoimmune disease, they may have dangerous side effects, including central nervous system damage, cardiac reactions, severe allergic reactions, serious infection, and lupus-like syndrome

E.HuangW.KostusiakM.PallierP

Patients with a BMI of 30 or higher are typically considered for this treatment, but those with a BMI of 27 or above who also have weight-related health conditions, such as diabetes or hypertension, may also benefit

Because of its delicate nature, it works well on a variety of skin types